Tempest Therapeutics Files 424B3 Prospectus
Ticker: TPST · Form: 424B3 · Filed: 2026-04-10T09:24:42-04:00
Sentiment: neutral
Topics: prospectus, securities-offering, filing
TL;DR
Tempest Therapeutics dropped a 424B3 filing on 4/10/26. Check it for new security info.
AI Summary
Tempest Therapeutics, Inc. filed a 424B3 prospectus on April 10, 2026, related to its securities. The filing details information about the company's offerings and operations, with its principal executive offices located at 2000 Sierra Point Parkway, Suite 400, Brisbane, CA 94005.
Why It Matters
This filing provides updated information to investors regarding Tempest Therapeutics' securities, which could influence investment decisions and market perception.
Risk Assessment
Risk Level: low — A 424B3 filing is a standard prospectus supplement and does not inherently indicate increased risk for the company.
Key Numbers
- 0001193125-26-150469 — SEC Accession Number (Unique identifier for this specific SEC filing)
- 333-294740 — File Number (Associated file number for the registration statement)
Key Players & Entities
- Tempest Therapeutics, Inc. (company) — Filer of the prospectus
- 2000 Sierra Point Parkway, Suite 400, Brisbane, CA 94005 (location) — Company's business and mailing address
- 0001544227 (company_id) — CIK number for Tempest Therapeutics, Inc.
- 2026-04-10 (date) — Filing date of the 424B3 prospectus
FAQ
What is the purpose of a 424B3 filing?
A 424B3 filing is a prospectus supplement used to provide additional information or updates to an already filed registration statement, often detailing the terms of securities being offered.
When was this specific 424B3 filing submitted by Tempest Therapeutics?
This 424B3 filing was submitted on April 10, 2026.
What is the CIK number for Tempest Therapeutics, Inc.?
The CIK number for Tempest Therapeutics, Inc. is 0001544227.
Where are Tempest Therapeutics' principal executive offices located?
Tempest Therapeutics' principal executive offices are located at 2000 Sierra Point Parkway, Suite 400, Brisbane, CA 94005.
What SIC code is associated with Tempest Therapeutics?
Tempest Therapeutics is associated with SIC code 2834, which pertains to Pharmaceutical Preparations.
From the Filing
EDGAR Filing Documents for 0001193125-26-150469 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 424B3 - Prospectus [Rule 424(b)(3)]: SEC Accession No. 0001193125-26-150469 Filing Date 2026-04-10 Accepted 2026-04-10 09:24:42 Documents 2 Document Format Files Seq Description Document Type Size 1 424B3 d104843d424b3.htm 424B3 77677 2 GRAPHIC g104843g03g03.jpg GRAPHIC 58950 Complete submission text file 0001193125-26-150469.txt 160268 Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589 Tempest Therapeutics, Inc. (Filer) CIK : 0001544227 (see all company filings) EIN. : 451472564 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 424B3 | Act: 33 | File No.: 333-294740 | Film No.: 26853366 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)